Low-Dose vs Standard Naltrexone
LDN (1.5–4.5 mg) is used for autoimmune modulation, chronic pain, and inflammation via transient opioid-receptor blockade and endorphin rebound. Standard 50 mg dosing is for opioid and alcohol use disorder. Indications are entirely distinct.
LDN is appropriate for autoimmune, inflammation, and chronic-pain indications under provider review.
Standard naltrexone is appropriate for opioid or alcohol use disorder.
Educational. Final pathway selection is provider-reviewed via synchronous video consultation against your biomarkers, history, and goals.
Frequently asked
Why is LDN compounded?
Standard tablets are not available at sub-5 mg doses.
Is LDN evidence-based?
Yes for select autoimmune contexts; emerging for others.
Take the optimization assessment.
The adaptive assessment maps your symptoms, history, and goals to candidate pathways — and routes you into provider review.
Begin assessment